In the world of women’s health, few areas have been as overlooked and underserved as pelvic health. For decades, patients suffering from chronic pelvic pain and related conditions have faced outdated treatments, limited options, and a lack of understanding from the medical community. Enter Hyivy Health, a Canadian startup that’s not just disrupting the status quo – it’s completely redefining how we…
A detailed map of the human endometrium, the inner lining of the uterus, has recently been released, offering new insights into the cellular processes that occur throughout the menstrual cycle. This research, which covers multiple phases of the cycle, has potential implications for understanding and treating conditions like endometriosis. The study, published in Nature Genetics, is part of the Human Cell Atlas…
GE HealthCare has announced a new collaboration with the University of California San Diego School of Medicine to enhance imaging techniques for diagnosing and managing female pelvic diseases, such as endometriosis and ovarian cancer. This partnership, which will be conducted through the Center for Translational Imaging and Precision Medicine (CTIPM) at UC San Diego, aims to develop advanced magnetic resonance imaging (MRI)…
Elvie, a leader in consumer health devices, is stepping into the digital health arena with the launch of Elvie Strong, a free app designed to support pelvic floor health. This is Elvie’s first venture into purely digital solutions, aiming to make health and wellness more accessible for women. Pelvic floor muscles are vital for overall health, impacting bladder control and sexual function.…
Amber Therapeutics, a UK-based medical technology company, has successfully closed a $100 million Series A financing round. The investment will advance their Amber-UI neuromodulation therapy towards US FDA approval. The financing round, one of the largest ever in Europe for a medical technology company, was led by New Enterprise Associates (NEA) with participation from F-Prime Capital, Lightstone Ventures, Intuitive Ventures, and existing…
Researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the University of California Davis have developed a human Cervix-on-a-Chip. This model accurately mimics the complex cervical tissue and addresses the limitations of current animal and in vitro models, enhancing the study of bacterial vaginosis (BV) and fostering the development of more effective treatments. Bacterial Vaginosis affects over 25%…
Axena Health, a medical device company dedicated to advancing female pelvic health, has successfully raised an additional $9.4 million in its Series A fundraising round. This latest tranche of funding saw participation from Cross-Border Impact Ventures (CBIV) alongside existing investors such as AXA IM Alts through its Global Healthcare Private Equity Strategy, KOFA Healthcare, and Avestria Ventures. As part of the investment,…
Nanopath, a point-of-care diagnostics company, has received $4 million in federal grants from the National Institutes of Health (NIH) and the National Science Foundation (NSF). This funding is intended to support the development of Nanopath’s diagnostic platform, which focuses on pelvic and gynecologic infections and diseases. The grants were awarded through the competitive Small Business Innovation Research (SBIR) Program. The total federal…
